HRQoL Consistently High for Out-of-Hospital Cardiac Arrest Survivors
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
FRIDAY, Sept. 15, 2023 -- For survivors of out-of-hospital cardiac arrest, long-term health-related quality of life is consistently high up to 20 years after the event, according to a study published online Sept. 13 in JAMA Cardiology.
Harman Yonis, M.D., from Nordsjællands Hospital in Hillerød, Denmark, and colleagues used the EuroQol Health Questionnaire (EQ index), 12-Item Short Form Health Survey (SF-12), and Hospital Anxiety and Depression Scale (HADS) to assess the health-related quality of life of 4,545 adult survivors of out-of-hospital cardiac arrest included in the Danish Cardiac Arrest Registry between June 1, 2001, and Aug. 31, 2019, who were alive in October 2020. The survey was completed by 56.1 percent of survivors, with a median follow-up of 5.5 years since their event.
The researchers found that the median EQ index score was 0.9 for both the shortest follow-up (zero to one year) and longest follow-up (>15 to 20 years) groups. The mean SF-12 physical and mental health scores were 43.3 and 52.9, respectively, for all responders. All three scores were similar to those from a general Danish reference population. Based on HADS scores, a low risk for anxiety was reported by 73.0 and 89.3 percent of the shortest and longest follow-up groups, respectively; these proportions were 79.7 and 87.5 percent, respectively, for symptoms of depression. In survivors across all follow-up periods, health-related quality of life was similar.
"These findings support resource allocation and efforts targeted to increasing survival after out-of-hospital cardiac arrest," the authors write.
Several authors disclosed ties to the biopharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted September 2023
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.